2017 EMA Veterinary Medicines Info Day Organised in collaboration with IFAH-Europe

‘The latest developments' in scientific review, regulation and marketing authorisation procedures 16-17 March 2017, European Medicines Agency (EMA), London Final Programme Thursday 16th March 2017 13:30

Registration opens

14:00

Introduction and welcome

Session I: Scientific developments 14:10

Chair: Rick Clayton (IFAH-Europe)

CVMP achievements 2016: Highlights and reflections (30’) David Murphy (Chair of CVMP)

14:40

Anthelmintic resistance: Status including feedback from the focus group meeting 13 June 2016 and presentation on the CVMP Reflection paper (20’) Gesine Hahn (EU expert, Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

15:00

Antimicrobial resistance (AMR): Presentation on the joint EMA/EFSA RONAFA opinion; harmonisation of SPCs of antimicrobial veterinary medicines under current legislation (20’) Helen Jukes (Chair of CVMP Antimicrobials working party)

15:20

Recent developments in environmental assessment (20’) Chris van den Eede (Zoetis/IFAH-Europe)

15:40

Questions (20’)

16:00

Coffee break (30’) – EMA info points

Session II: Availability of veterinary medicines 16:30

Chair: Fia Westerholm (EMA)

Vaccine availability: -

Action plan (20’)

Faye Ioannou (EMA)

-

Industry perspective (action plan and progress following 2015 workshop) (20’)

Frédéric Descamps (Zoetis/IFAH-Europe)

17:10

Impact of future legislation on availability (20’) Pablo Hervas (Veterindustria/IFAH-Europe)

17:50

Questions (20’)

18:00

Cocktail reception at The Pearson Room Restaurant, followed by walking buffet from 18:45

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5505 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Friday 17th March 2017 Session III: Innovation 09:00

Chair: Roxane Feller (IFAH-Europe)

Horizon scanning: General outcome from meetings with industry; Early support for novel types of products (15’) Fia Westerholm (EMA)

09:15

Innovation: How to make legislation more supportive for innovation (15’) Peter Oostenbach (MSD/IFAH-Europe)

09:30

Update on ADVENT and progress on Q&A documents: experience with predrafting consultations (10’) Minna Leppänen (EMA)

09:40

Questions (15’)

Session IV: EU Procedural updates 09:55

Chair: Melanie Leivers (EMA)

Recent experiences with centralised procedure: opportunities for development (10’) Teresa Potter (EMA)

10:05

Best practice guide on adherence to timetables: status update (15’) Piotr Kozarewicz (EMA)

10:20

Questions (15’)

10.35

EMA procedural updates (15’) Emily Drury (EMA)

10:50

Questions (15’)

11:05

Coffee break (30’) – EMA info points

Session V: Regulatory policy 11:35

Future Legislation: harmonisation of SPCs: -

Industry viewpoint (15’)

Emmanuelle Royer (Caroline Toulemonde) (Merial/IFAH-Europe)

11:50

Questions (10’)

12:00

Future Legislation: pharmacovigilance:

12:40

Chair: David Mackay (EMA)

-

Pharmacovigilance and product data (20’)

-

Industry Vision (20’)

Jos Olaerts (EMA)

Tony Simon (Zoetis/IFAH-Europe)

Questions (10’)

Close of the meeting (5’)

2017 EMA Veterinary Medicines Info Day Organised in collaboration with IFAH-Europe EMA/595779/2016

Fia Westerholm (EMA); Rick Clayton (IFAH-Europe)

Page 2/2

Agenda - European Medicines Agency veterinary medicines info day

Send a question via our website www.ema.europa.eu/contact. © European Medicines ... Innovation: How to make legislation more supportive for innovation (15').

93KB Sizes 7 Downloads 79 Views

Recommend Documents

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - under Article 107i of Directive 2001/83/EC, based on pharmacovigilance data. Action: For adoption of ..... manufacturing process; and 3) removal of the following missing information: special patient groups. Action: For .... analysis of

Agenda - Adaptive pathways workshop - European Medicines Agency
Dec 6, 2016 - early access tools. Francesca Cerreta. (EMA). 09.15-. 09.30 ... Methodological challenges and the monitoring advantage of Real World Data.

Agenda - European Medicines Agency - Europa EU
4 days ago - Meningococcal group A, C, W135 and Y conjugate vaccine - NIMENRIX (CAP) -. EMEA/H/C/002226/II/0078 . ...... Applicant: AstraZeneca AB.

Agenda - Public hearing: Valproate - European Medicines Agency
Sep 26, 2017 - Daniel Hawcutt, Royal College of Paediatrics and Child Health (RCPCH), UK ... Kim Morley, Epilepsy specialist midwife/ nurse practitioner, UK.